The Covid-19 pandemic triggered a shift to remote working that has boosted the adoption of virtual reality (VR) by enterprises for training, collaboration, data visualisation and customer experience. With new technologies such as virtual and augmented reality being implemented more often in the healthcare industry, companies are discovering more ways new technologies can be used. More companies are starting to study ways to use VR in physiotherapy and treating various neurological disorders. XRHealth, a US-based virtual healthcare platform, has published a study that shows the potential of using VR technologies in upper limb dysfunction in multiple sclerosis patients.
The use of VR is expanding in the healthcare industry, along with other new technologies such as machine learning and artificial intelligence. According to GlobalData, the VR market, worth nearly $7bn in 2018, will have become a $28bn industry by 2030, having grown at a compound annual growth rate (CAGR) of 13% over that period. The research done by XRHealth indicates that VR technology is not only viable in treating upper limb dysfunction but is safe, reliable and fun for patients. Furthermore, patients’ experience during VR sessions was overseen and adjusted according to the patient’s needs by the physical therapist.
VR therapy could become a more common form of therapy for neurological diseases in the upcoming years due to its benefits. VR is very likely to become one of the key technologies in the future of healthcare and other industries, and the development of enterprise-grade metaverse platforms will further enhance its appeal.